Literature DB >> 14974113

Ultrasound screening of fetal structural abnormalities at 12 to 14 weeks in Hong Kong.

Min Chen1, Yung Hang Lam, Chin Peng Lee, Mary Hoi Yin Tang.   

Abstract

OBJECTIVE: Ultrasound screening for fetal abnormalities is conventionally performed at 18 to 20 weeks of gestation. Recent data suggested that many fetal structural abnormalities could be detected by ultrasound examination at 12 to 14 weeks of pregnancy. In this study, we investigated the effectiveness of early ultrasound examination in the detection of fetal abnormalities in women aged 35 years or older.
METHODS: From February 1998 to March 2001, pregnant women aged 35 or above were examined by transabdominal and transvaginal sonography between 12 and 14 weeks of gestation. If the anatomical survey was normal, the women underwent routine 16- to 20-week ultrasound examination. Pregnancy outcome was obtained from the hospital records or by contacting the subjects.
RESULTS: Twenty-six of the 1609 fetuses had structural abnormalities. Fourteen were detected at the ultrasound examination at 12 to 14 weeks. Detection rate was 53.8% (14/26; 95% CI 44, 64) with a false-positive rate of 0.3% (5/1583; 95% CI 0.16, 0.44). Six additional abnormalities (23.1%, 6/26) were detected at 16- to 20-week ultrasound examination. The overall detection rate of structural abnormalities was 76.9% (20/26; 95% CI 68.6, 85.2).
CONCLUSIONS: The effectiveness of ultrasound examination at 12 to 14 weeks to screen for fetal abnormalities approached that achieved at 20 weeks and can be a good adjunct to the conventional examination. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 14974113     DOI: 10.1002/pd.798

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  9 in total

1.  The Performance of First-Trimester Anatomy Scan: A Decision Analysis.

Authors:  Lorie M Harper; S Lindsay Wood; Sheri M Jenkins; John Owen; Joseph R Biggio
Journal:  Am J Perinatol       Date:  2016-04-22       Impact factor: 1.862

Review 2.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 3.  First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 4.  Second trimester serum tests for Down's Syndrome screening.

Authors:  S Kate Alldred; Jonathan J Deeks; Boliang Guo; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

5.  The value of screening for major fetal abnormalities during the nuchal translucency examination.

Authors:  Deborah Wye; Ron Benzie
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

Review 6.  First trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-11-30

Review 7.  Urine tests for Down's syndrome screening.

Authors:  S Kate Alldred; Boliang Guo; Yemisi Takwoingi; Mary Pennant; Susanna Wisniewski; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10

8.  The contribution and the importance of modern ultrasound techniques in the diagnosis of major structural abnormalities in the first trimester - case reports.

Authors:  R Dragusin; M Florea; D Iliescu; Smarandita Cotarcea; Stefania Tudorache; Liliana Novac; N Cernea
Journal:  Curr Health Sci J       Date:  2012-03-21

9.  First-trimester ultrasound detection of fetal heart anomalies: systematic review and meta-analysis.

Authors:  J N Karim; E Bradburn; N Roberts; A T Papageorghiou
Journal:  Ultrasound Obstet Gynecol       Date:  2022-01       Impact factor: 8.678

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.